1. CCLHD Research Repositories

Dasantha Jayamanne

View Statistics Email Alert RSS Feed

Profile

Loading... 2 0 20 0 false
Credit Name
Dasantha Jayamanne
Full Name
Jayamanne, Dasantha
ORCID
Loading... 3 0 20 0 false

Publications

Results 1-20 of 20 (Search time: 0.003 seconds).

PreviewIssue DateTitleAuthor(s)
123-Oct-2024Nature and impact of symptoms at time of initial presentation for patients with glioblastomaRuisi, Isidoro; Jayamanne, Dasantha ; Kastelan, Marina; Cove, Nicola ; Cheng, Michael; Back, Michael 
215-Sep-2023Leptomeningeal neuraxis relapse in glioblastoma is an uncommon but not rare event associated with poor outcomeWegener, Eric; Horsley, Patrick; Wheeler, Helen; Jayamanne, Dasantha ; Kastelan, Marina; Guo, Linxin; Brown, Chris; Back, Michael 
3Jan-2022Large tumour volume reduction of IDH-mutated anaplastic glioma involving the insular region following radiotherapyJayamanne, Dasantha ; Wong, Matthew ; Back, Michael ; Metz, G.; Wheeler, H.; Cook, R.; Little, N.; Parkinson, J.; Kastelan, M.; Brown, C.
42-Nov-2021Volumetric Response of Limited Brain Metastatic Disease to Focal Hypofractionated Radiation TherapyWijetunga, Asanka R; Jayamanne, Dasantha ; Adams, Jessica; Back, Michael 
59-Jun-2021Redo craniotomy or bevacizumab for symptomatic steroid-refractory true or pseudoprogression following IMRT for glioblastomaCook, Theresa A ; Jayamanne, Dasantha ; Wong, Matthew ; Cove, Nicola ; Back, Michael ; Wheeler, H.; Parkinson, J.; Cook, R. J.; Kastelan, M. A.; Brown, C.
6Mar-2020The role of large volume re-irradiation with Bevacizumab in chemorefractory high grade gliomaWong, Matthew ; Jayamanne, Dasantha ; Back, Michael ; Chan, J.; Wheeler, H.; Khasraw, M.; Kastelan, M.; Guo, L.
7Jun-2019Reflecting on survivorship outcomes to aid initial decision making in patients treated for IDH-mutated anaplastic gliomaJayamanne, Dasantha ; Wong, Matthew ; Back, Michael ; Back, E.; Kastelan, M.; Khasraw, M.; Brown, C.; Wheeler, H.
8May-2019Role of delayed salvage bevacizumab at symptomatic progression of chemorefractory glioblastomaCuncannon, Moire ; Wong, Matthew ; Jayamanne, Dasantha ; Cove, Nicola ; Back, Michael ; Guo, L.; Wheeler, H.
9Apr-2019Influence of molecular classification in anaplastic glioma for determining outcome and future approach to managementBack, Michael ; Jayamanne, Dasantha ; Wong, Matthew ; Brazier, D.; Newey, A.; Bailey, D.; Schembri, G; Hsiao, E.; Khasraw, M.; Kastelan, M.; Guo, L.; Clarke, S.; Wheeler, H.
10Apr-2019Pattern of failure in anaplastic glioma patients with an IDH1/2 mutationBack, Michael ; Jayamanne, Dasantha ; Wong, Matthew ; Brazier, D.; Newey, A.; Bailey, D.; Schembri, G.; Hsiao, E.; Khasraw, M.; Kastelan, M.; Brown, C.; Wheeler, H.
11Apr-2019Focal radiation therapy for limited brain metastases is associated with high rates of local control and low subsequent whole brain radiation therapyJayamanne, Dasantha ; Stevens, Mark ; Back, Michael ; Or, M.; Guo, L.; Parkinson, J.; Cook, R.; Little, N.
12Dec-2018FET PET in the evaluation of indeterminate brain lesions on MRI: Differentiating glioma from other non-neoplastic causes - A pilot studyBack, Michael ; Jayamanne, Dasantha ; Chan, D.L.; Hsiao, E.; Schembri, G.; Bailey, D.; Roach, P.J.; Lee, A.; Ghasemzadeh, M.; Hayes, A.R.; Cook, R.; Parkinson, J.; Drummond, J.P.; Ibbett, I.; Wheeler, H.
13Nov-2018Tumour volume reduction following PET guided intensity modulated radiation therapy and temozolomide in IDH mutated anaplastic gliomaBack, Michael ; Jayamanne, Dasantha ; Brazier, D.; Bailey, D.; Hsiao, E.; Guo, L.; Wheeler, H.
14Oct-2018Optimising Outcomes for Glioblastoma through Subspecialisation in a Regional Cancer CentreBack, Michael ; Jayamanne, Dasantha ; Wong, Matthew ; Cove, N.; Wheeler, H.; Khasraw, M.; Guo, L.; Back, J.
15Sep-2018Understanding the Revised Fourth Edition of the World Health Organization Classification of Tumours of the Central Nervous System (2016) for Clinical Decision-making: A Guide for Oncologists Managing Patients with GliomaBack, Michael ; Jayamanne, Dasantha ; Rodriguez, M.; Khasraw, M.; Lee, A.; Wheeler, H.
16Jul-2018Utilizing 18F-fluoroethyltyrosine (FET) positron emission tomography (PET) to define suspected nonenhancing tumor for radiation therapy planning of glioblastomaJayamanne, Dasantha ; Back, Michael ; Hayes, A.R.; Hsiao, E.; Schembri, G.; Bailey, D.; Roach, P.J.; Khasraw, M.; Newey, A.; Wheeler, H.
17Jayamanne-2018-Predicting patterns of failure.pdf.jpgJul-2018Predicting patterns of failure in temporal lobe GBMs: Possible implications on radiotherapy treatment portalsJayamanne, Dasantha ; Back, Michael ; Wheeler, H.; Brazier, D.; Newey, A.; Kastelan, M.; Guo, L.
18Mar-2018Survival improvements with adjuvant therapy in patients with glioblastomaJayamanne, Dasantha ; Back, Michael ; Wheeler, H.; Cook, R.; Teo, C.; Brazier, D.; Schembri, G.; Kastelan, M.; Guo, L.
19Feb-2018Utilizing 18F-fluoroethyl-l-tyrosine positron emission tomography in high grade glioma for radiation treatment planning in patients with contraindications to MRIJayamanne, Dasantha ; Back, Michael ; Kaushal, Sneha ; Chan, D.L.; Schembri, G.; Brazier, D.; Bailey, D.; Wheeler, H.
20Jul-2017Survival Outcomes of Elderly Patients With Glioblastoma Multiforme in Their 75th Year or Older Treated With Adjuvant TherapyBack, Michael ; Jayamanne, Dasantha ; Harris, G.; Wheeler, H.; Gzell, C.; Kastelan, M.; Schembri, G.; Brazier, D.; Cook, R.; Parkinson, J.; Khasraw, M.; Louw, S.